Bronx, NY, United States of America

Denis E Reyna

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Albert Einstein College of Medicine. Active years: 2022-2024.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Cancer Therapy by Denis E Reyna

Introduction

Denis E Reyna is a prominent inventor based in the Bronx, NY (US). He has made significant contributions to the field of cancer therapy through his innovative research and patents. With a total of 2 patents, Reyna is dedicated to advancing medical science and improving treatment options for cancer patients.

Latest Patents

Reyna's latest patents focus on BAX activators and their applications in cancer therapy. These activators are designed to enhance the effectiveness of cancer treatments by targeting specific pathways involved in tumor growth. The patents detail the mechanisms of BAX activators and their potential uses in therapeutic settings, providing valuable insights for future research and clinical applications.

Career Highlights

Denis E Reyna is affiliated with the Albert Einstein College of Medicine, where he conducts his research. His work is characterized by a commitment to understanding the complexities of cancer biology and developing innovative solutions to combat this disease. His contributions have been recognized within the scientific community, and he continues to push the boundaries of cancer research.

Collaborations

Reyna collaborates with esteemed colleagues such as Evripidis Gavathiotis and Felix Kopp. These partnerships enhance the scope of his research and foster a collaborative environment that encourages innovation and discovery.

Conclusion

Denis E Reyna's work in cancer therapy exemplifies the impact of innovative research on medical science. His patents on BAX activators represent a significant step forward in the fight against cancer, showcasing his dedication to improving patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…